Replies to post #210058 on Biotech Values

[DewDiligence]

GLMD -15%/AH on sale of 381K shares @$7.10 in registered direct offering (of which insiders are buying 49K shares):

http://www.prnewswire.com/news-releases/galmed-pharmaceuticals-announces-pricing-of-offering-of-ordinary-shares-to-existing-investors-and-members-of-the-board-of-directors-300499533.html

The selloff in AH trading is presumably due to the fact that the company was able to raise only $2.7M (gross proceeds) from this offering. They need more.